Engineering Glioma-Cell-Derived Exosomes as Trojan Horse for Precisely Targeted Chemotherapy of Glioblastoma
Biomaterials Research · 01.01.2026 · 30
DOI: 10.34133/bmr.0365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Research, online erschienen am 02.06.2026. Verfasst von Zhijun He und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of New Ceramic Materials, Key Laboratory of Advanced Materials, School of Materials Science and Engineering, Tsinghua University…. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Beijing Nova Program, Beijing Natural Science Foundation.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The management of glioblastoma multiforme (GBM) remains challenging due to its poor prognosis and extremely high postoperative recurrence rate. Although the Gliadel wafer locally delivers carmustine, its clinical application is limited by suboptimal therapeutic efficacy and poor conformability to irregular resection cavities. To overcome these limitations, we developed a novel drug delivery system based on thermosensitive injectable chitosan-β-glycerol phosphate hydrogel containing doxorubicin-loaded mesoporous silica nanoparticles encapsulated within tumor-derived exosomes (Exo-DMSNs@CS). In an orthotopic mouse GBM relapse model recapitulating clinical tumor resection, the liquid Exo-DMSNs@CS formulation was injected into the surgical cavity and subsequently gelated in situ, achieving seamless adhesion to the irregular resection margins of the cavity. The exosome-coated nanoparticles (Exo-DMSNs), released gradually from chitosan hydrogel, exhibited enhanced tumor-targeting capability via exosome-mediated tumor-homing performance, thereby substantially promoting drug internalization. Compared to non-exosomal controls (DMSNs@CS), Exo-DMSNs@CS markedly suppressed tumor recurrence and prolonged survival. Our findings demonstrate that this Trojan-horse-inspired delivery strategy—leveraging tumor-derived exosomes to encapsulate drug-loaded nanoparticles—enables a localized and precise tumor-targeted drug delivery system, representing a promising therapeutic paradigm for GBM treatment.
Autor:innen und Institutionen
- State Key Laboratory of New Ceramic Materials, Key Laboratory of Advanced Materials, School of Materials Science and Engineering, Tsinghua University, Beijing 100084, China.
- Department of Neurosurgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China.
- School of Life Science, Tsinghua University, Beijing 100084, China.
- Department of Neurosurgery, Shandong Provincial Third Hospital, Shandong University, Shandong 250031, China.
- Department of Neurology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China.
ORCID-Profile: Xiumei Wang
Förderung
- National Natural Science Foundation of China
- Beijing Nova Program
- Beijing Natural Science Foundation
Zitieren
APA
He, Z., Meng, Z., Luan, G., Li, P., Yang, C., Liang, Y., Sun, X., Zhao, L., Wang, G., & Wang, X. (2026). Engineering Glioma-Cell-Derived Exosomes as Trojan Horse for Precisely Targeted Chemotherapy of Glioblastoma. Biomaterials Research, 30. https://doi.org/10.34133/bmr.0365
Vancouver
He Z, Meng Z, Luan G, Li P, Yang C, Liang Y, et al. Engineering Glioma-Cell-Derived Exosomes as Trojan Horse for Precisely Targeted Chemotherapy of Glioblastoma. Biomaterials Research. 2026;30. doi:10.34133/bmr.0365
BibTeX
@article{He2026,
author = {He, Zhijun and Meng, Zhe and Luan, Guoxi and Li, Pengbo and Yang, Chunyi and Liang, Yifan and Sun, Xiaodan and Zhao, Lingyun and Wang, Guihuai and Wang, Xiumei},
title = {Engineering Glioma-Cell-Derived Exosomes as Trojan Horse for Precisely Targeted Chemotherapy of Glioblastoma},
journal = {Biomaterials Research},
year = {2026},
volume = {30},
doi = {10.34133/bmr.0365}
}
EUVIMED